Bivalent analgesics: rational design of selective ion channel inhibitors with optimised mechanism of action (2021–2023)

Grant type:
NHMRC IDEAS Grants
Researchers:
  • NHMRC Leadership Fellow - Group Lea
    Institute for Molecular Bioscience
    NHMRC Leadership Fellow - Group Lea
    School of Pharmacy
    Faculty of Health and Behavioural Sciences
    NHMRC Leadership Fellow - Group Lea
    Institute for Molecular Bioscience
  • ARC DECRA
    Institute for Molecular Bioscience
  • Professorial Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
    Professorial Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
    Affiliate Associate Professor
    Institute for Molecular Bioscience
    Affiliate Associate Professor
    School of Chemistry and Molecular Biosciences
    Faculty of Science
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
Funded by:
National Health and Medical Research Council